Loading...
Loading...

Go to the content (press return)

Characteristics of apixaban-treated patients, evaluation of the dose prescribed, and the persistence of treatment: a cohort study in Catalonia

Author
Gómez-Lumbreras, A.; Cortes, J.; Giner-Soriano, M.; Quijada-Manuitt, M.; Morros, R.
Type of activity
Journal article
Journal
Journal of cardiovascular pharmacology and therapeutics
Date of publication
2018-05-23
Volume
23
Number
6
First page
494
Last page
501
DOI
10.1177/1074248418778544
Repository
http://hdl.handle.net/2117/132728 Open in new window
URL
http://journals.sagepub.com/eprint/6NYnn9mhQjp8Q9rr65X9/full Open in new window
Abstract
Apixaban is a direct oral anticoagulant, which inhibits factor Xa. It has demonstrated clinical efficacy in prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation and a better safety profile compared to warfarin. Objectives: (1) To describe the characteristics of patients with nonvalvular atrial fibrillation beginning treatment with apixaban, (2) to analyze concomitant prescriptions of medications that could potentially interact with apixaban, (3) to ev...
Citation
Gómez-Lumbreras, A. [et al.]. Characteristics of apixaban-treated patients, evaluation of the dose prescribed, and the persistence of treatment: a cohort study in Catalonia. "Journal of cardiovascular pharmacology and therapeutics", 23 Maig 2018, vol. 23, núm. 6, p. 494-501.
Keywords
anticoagulants, apixaban, drug use review, electronic health records, medication adherence
Group of research
GRBIO - Biostatistics and Bioinformatics Research Group

Participants

  • Gómez Lumbreras, Ainhoa  (author)
  • Cortes Martinez, Jordi  (author)
  • Giner Soriano, Maria  (author)
  • Quijada Manuitt, Mª Angeles  (author)
  • Morros Padrós, Rosa  (author)

Attachments